IP Library › Granted Patent US 11,090,477
Granted Patent B2
US 11,090,477 · App. 16/109,376 · Granted Aug 17, 2021

IV access port cap for providing antimicrobial protection

Inventors: Yiping Ma (Layton, UT); Siddarth Shevgoor (Laguna Beach, CA)
Assignee: Becton, Dickinson and Company
A61M39/162A61M25/0017A61M39/20A61M39/0208A61M39/165A61M2025/0056
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,090,477
App. No.
16/109,376
Granted
Aug 17, 2021
Kind
B2
Abstract

A cap is configured to provide antimicrobial protection to a female luer port of an intravenous device. The cap distributes an antimicrobial solution within the intraluminal surfaces of the port when the cap is connected to the port. A cap may also be designed to distribute an antimicrobial solution around the exterior surfaces of the port. Once connected to a port, the cap can form a seal that minimizes the evaporation of the antimicrobial solution from within the lumen of a port. The cap can therefore provide antimicrobial protection against another device that is connected to the port once the cap is removed.

Claims (20)

1. A cap for a port of an intravenous device, the cap comprising:

a body, comprising a first end, a second end opposite the first end, and a cavity disposed between the first end and the second end, wherein the second end of the body comprises a luer connector configured to couple to a port;

an actuator, wherein an end of the actuator is disposed within the cavity, wherein the actuator comprises a protrusion having a lumen; and

an absorbent material containing an antimicrobial solution, the absorbent material disposed within the cavity, wherein the absorbent material is compressible, wherein the end of the actuator is configured to move towards the first end of the body to contact and compress the absorbent material, wherein in response to compression of the absorbent material by the end of the actuator, the antimicrobial solution flows through the lumen of the protrusion.

2. The cap of claim 1 , wherein the protrusion comprises a male luer in which the lumen is formed.

3. The cap of claim 1 , wherein the antimicrobial solution flows through a gap between the body and an exterior surface of the actuator in response to movement of the end of the actuator towards the first end of the body to contact and compress the absorbent material.

4. The cap of claim 1 , wherein the body includes a seal configured to contact the end of the actuator.

5. The cap of claim 1 , wherein the actuator includes a plurality of prongs that extend through corresponding openings in the body.

6. The cap of claim 1 , wherein the lumen comprises an antimicrobial coating.

7. The cap of claim 1 , wherein the luer connector is threaded.

8. The cap of claim 5 , wherein the antimicrobial solution is configured to flow through the openings.

9. A cap for a port of an intravenous device, the cap comprising:

a body, comprising a first end, a second end opposite the first end, and having a cavity disposed between the first end and the second end, wherein the second end of the body comprises a luer connector configured to couple to a port;

an actuator, wherein an end of the actuator is disposed within the cavity, wherein the actuator comprises a protrusion having a lumen; and

an absorbent material containing an antimicrobial solution, the absorbent material disposed within the cavity, wherein the absorbent material is compressible, wherein the end of the actuator is configured to move towards the first end of the body to contact and compress the absorbent material, wherein in response to compression of the absorbent material by the end of the actuator, the antimicrobial solution flows through the lumen of the protrusion;

wherein prior to the cap being connected to the port, the absorbent material remains uncompressed.

10. The cap of claim 9 , wherein the actuator is sized such that a gap exists between an outer edge of the actuator and a wall of the cavity, the antimicrobial solution configured to flow through the gap.

11. The cap of claim 9 , wherein the body includes a seal for sealing the lumen of the actuator.

12. The cap of claim 9 , wherein the protrusion comprises a male luer.

13. The cap of claim 10 , wherein the actuator includes a plurality of prongs which extend through corresponding openings in the body, the antimicrobial solution configured to flow through the openings.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 8, 2018
From: MA, YIPING; SHEVGOOR, SIDDARTH
To: BECTON, DICKINSON AND COMPANY
Reel/Frame 047090/0799 →
Continuity (4)
Continuation 15674389 · Aug 10, 2017
Continuation 15041931 · Feb 11, 2016
Continuation 14185827 · Feb 20, 2014
Related Publication 20190001115A1 · Jan 3, 2019